BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 14654942)

  • 1. Involvement of the mitogen-activated protein kinase kinase 2 in the induction of cell dissociation in pancreatic cancer.
    Tan X; Egami H; Kamohara H; Ishikawa S; Kurizaki T; Yoshida N; Tamori Y; Takai E; Hirota M; Ogawa M
    Int J Oncol; 2004 Jan; 24(1):65-73. PubMed ID: 14654942
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Analysis of invasion-metastasis mechanism in pancreatic cancer: involvement of tight junction transmembrane protein occludin and MEK/ERK signal transduction pathway in cancer cell dissociation.
    Tan X; Tamori Y; Egami H; Ishikawa S; Kurizaki T; Takai E; Hirota M; Ogawa M
    Oncol Rep; 2004 May; 11(5):993-8. PubMed ID: 15069537
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Relationship between the expression of extracellular signal-regulated kinase 1/2 and the dissociation of pancreatic cancer cells: Involvement of ERK1/2 in the dissociation status of cancer cells.
    Tan X; Egami H; Ishikawa S; Kurizaki T; Tamori Y; Takai E; Hirota M; Ogawa M
    Int J Oncol; 2004 Apr; 24(4):815-20. PubMed ID: 15010817
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Relationship between activation of epidermal growth factor receptor and cell dissociation in pancreatic cancer.
    Tan X; Egami H; Ishikawa S; Nakagawa M; Ishiko T; Kamohara H; Hirota M; Ogawa M
    Int J Oncol; 2004 Nov; 25(5):1303-9. PubMed ID: 15492819
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Arrangement of expression and distribution of tight junction protein claudin-1 in cell dissociation of pancreatic cancer cells.
    Tan X; Egami H; Ishikawa S; Kurizaki T; Nakagawa M; Hirota M; Ogawa M
    Int J Oncol; 2004 Dec; 25(6):1567-74. PubMed ID: 15547692
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Involvement of matrix metalloproteinase-7 in invasion-metastasis through induction of cell dissociation in pancreatic cancer.
    Tan X; Egami H; Ishikawa S; Sugita H; Kamohara H; Nakagawa M; Nozawa F; Abe M; Ogawa M
    Int J Oncol; 2005 May; 26(5):1283-9. PubMed ID: 15809719
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Involvement of MMP-7 in invasion of pancreatic cancer cells through activation of the EGFR mediated MEK-ERK signal transduction pathway.
    Tan X; Egami H; Abe M; Nozawa F; Hirota M; Ogawa M
    J Clin Pathol; 2005 Dec; 58(12):1242-8. PubMed ID: 16311341
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Correlation of translocation of tight junction protein Zonula occludens-1 and activation of epidermal growth factor receptor in the regulation of invasion of pancreatic cancer cells.
    Takai E; Tan X; Tamori Y; Hirota M; Egami H; Ogawa M
    Int J Oncol; 2005 Sep; 27(3):645-51. PubMed ID: 16077912
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of genes related to invasion and metastasis in pancreatic cancer by cDNA representational difference analysis.
    Ishikawa S; Egami H; Kurizaki T; Akagi J; Tamori Y; Yoshida N; Tan X; Hayashi N; Ogawa M
    J Exp Clin Cancer Res; 2003 Jun; 22(2):299-306. PubMed ID: 12866581
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of RAF/MEK/ERK pathway, p-STAT-3 and Mcl-1 in sorafenib activity in human pancreatic cancer cell lines.
    Ulivi P; Arienti C; Amadori D; Fabbri F; Carloni S; Tesei A; Vannini I; Silvestrini R; Zoli W
    J Cell Physiol; 2009 Jul; 220(1):214-21. PubMed ID: 19288493
    [TBL] [Abstract][Full Text] [Related]  

  • 11. p21WAF1 expression induced by MEK/ERK pathway activation or inhibition correlates with growth arrest, myogenic differentiation and onco-phenotype reversal in rhabdomyosarcoma cells.
    Ciccarelli C; Marampon F; Scoglio A; Mauro A; Giacinti C; De Cesaris P; Zani BM
    Mol Cancer; 2005 Dec; 4():41. PubMed ID: 16351709
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Resistance to mitogen-activated protein kinase kinase (MEK) inhibitors correlates with up-regulation of the MEK/extracellular signal-regulated kinase pathway in hepatocellular carcinoma cells.
    Yip-Schneider MT; Klein PJ; Wentz SC; Zeni A; Menze A; Schmidt CM
    J Pharmacol Exp Ther; 2009 Jun; 329(3):1063-70. PubMed ID: 19258520
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differential sensitivity of chemoresistant neuroblastoma subtypes to MAPK-targeted treatment correlates with ERK, p53 expression, and signaling response to U0126.
    Eppstein AC; Sandoval JA; Klein PJ; Woodruff HA; Grosfeld JL; Hickey RJ; Malkas LH; Schmidt CM
    J Pediatr Surg; 2006 Jan; 41(1):252-9. PubMed ID: 16410143
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Overexpression of the cytokine osteopontin identifies aggressive laryngeal squamous cell carcinomas and enhances carcinoma cell proliferation and invasiveness.
    Celetti A; Testa D; Staibano S; Merolla F; Guarino V; Castellone MD; Iovine R; Mansueto G; Somma P; De Rosa G; Galli V; Melillo RM; Santoro M
    Clin Cancer Res; 2005 Nov; 11(22):8019-27. PubMed ID: 16299231
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Involvement of MEK-ERK signaling pathway in the inhibition of cell growth by troglitazone in human pancreatic cancer cells.
    Motomura W; Tanno S; Takahashi N; Nagamine M; Fukuda M; Kohgo Y; Okumura T
    Biochem Biophys Res Commun; 2005 Jun; 332(1):89-94. PubMed ID: 15896303
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MEK inhibitor enhances the inhibitory effect of imatinib on pancreatic cancer cell growth.
    Takayama Y; Kokuryo T; Yokoyama Y; Nagino M; Nimura Y; Senga T; Hamaguchi M
    Cancer Lett; 2008 Jun; 264(2):241-9. PubMed ID: 18346844
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effect of doxorubicin on MEK-ERK signaling predicts its efficacy in HCC.
    Choi J; Yip-Schneider M; Albertin F; Wiesenauer C; Wang Y; Schmidt CM
    J Surg Res; 2008 Dec; 150(2):219-26. PubMed ID: 18468633
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Correlation of gene expression of ATP-binding cassette protein and tyrosine kinase signaling pathway in patients with hepatocellular carcinoma.
    Hoffmann K; Shibo L; Xiao Z; Longerich T; Büchler MW; Schemmer P
    Anticancer Res; 2011 Nov; 31(11):3883-90. PubMed ID: 22110214
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cloning and characterization of cDNAs encoding chicken mitogen-activated protein kinase kinase type 2, MEK2: downregulation of MEK2 in response to inhibition of mitochondrial DNA expression.
    Wang H; Meury L; Morais R
    Biochemistry; 1997 Dec; 36(49):15371-80. PubMed ID: 9398267
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Aryl hydrocarbon receptor activation and cytochrome P450 1A induction by the mitogen-activated protein kinase inhibitor U0126 in hepatocytes.
    Andrieux L; Langouët S; Fautrel A; Ezan F; Krauser JA; Savouret JF; Guengerich FP; Baffet G; Guillouzo A
    Mol Pharmacol; 2004 Apr; 65(4):934-43. PubMed ID: 15044623
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.